Why Is Cerevel Therapeutics (CERE) Stock Up 12% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Cerevel Therapeutics stock is climbing higher as CERE investors react to an $8.7 billion acquisition deal with AbbVie.

The post Why Is Cerevel Therapeutics (CERE) Stock Up 12% Today? appeared first on InvestorPlace.

• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors